Lung Cancer Screening and Identification
of Lung Cancer Patients at All Stages

Access presentation PDF here (opens in new window).

For the second installment of a three part webinar series, join Dr. Mullett from the University of Kentucky Markey Cancer Center as he discusses the screening, management and treatment of lung cancer patients.

Key learnings include:

1. Who is eligible for screening
2. Management of positive findings
3. Management of treatment options using a multidisciplinary care approach and the value of tumor boards
4. Importance of clinical trial participation

Featured Speaker

Timothy Mullett, MD, MBA, FACS

Associate Professor of Surgery in the Division of Cardiothoracic Surgery
University of Kentucky College of Medicine

Dr. Mullett, Medical Director, Markey Cancer Center Affiliate Network, is a surgical oncologist who specializes in the treatment of lung cancer. Although he began his career at the University of Kentucky as a cardiothoracic surgeon treating heart issues, he soon shifted his professional focus to treating lung cancer, one of the state’s major health problems. Today, he is a co-leader and principal investigator of the Kentucky LEADS Collaborative to improve lung cancer survival.

In addition to his work in lung cancer research, Dr. Mullett serves as the chair of UK’s cancer committee and the medical director of the Markey Cancer Center Research Network, a collaborative network that conducts high priority trials including therapeutic oncology trials and interventional and non-interventional studies for community centers.

Dr. Mullett currently serves as chair of the Commission on Cancer (CoC) of the American College of Surgeons (ACS).

All Sessions